Recent advances in chemical synthesis methods and biotechnologies have enabled biomedical research at the interface of chemistry and biology. This multidisciplinary, collaborative research approach has facilitated the modular design and development of precision nanomedicines in the diagnosis and treatment of many diseases, including cancer.
In this presentation Dr. Sabatino will highlight the successful biomedical research program within the Department of Chemistry at Carleton University engaging faculty, students, and leading scientists across our campus and beyond. For more information about Dr. Sabatino and his research visit the Sabatino Lab website.
About the Presenter
Dr. David Sabatino was born and raised in Montreal, Quebec Canada where he completed his B.Sc. (2002) and Ph.D. (2007) at McGill University in the area of nucleic acid biochemistry. As a research fellow, he completed his post-doctoral training at l’Université de Montréal in 2010 developing new methods in the chemical synthesis of peptide mimics.
Dr. Sabatino was then appointed as faculty in the Department of Chemistry and Biochemistry at Seton Hall University and also held a joint appointment in the Department of Medical Sciences at the Hackensack-Meridian School of Medicine where he was engaged in multiple biomedical research collaborations. In January 2022, Dr. Sabatino joined the Faculty of Science in the Department of Chemistry at Carleton University where he currently serves as Associate Professor.
Dr. Sabatino has received funding support from the federal government (NIH/NCI) for research related to the development of anti-cancer treatment strategies. His research accomplishments have been recognized and awarded, with being most recently nominated Researcher of the Year in 2019 at Seton Hall University.